Aerovate Therapeutics, Inc.

TickerCurrent Price% Daily ChangeVolume (1,000s)Average Volumn (1,000s)Market Cap (Millions)1/2/2024 Price% Change Since Inception 1/2/2024
AVTE$1.463.546%3,854703$42$21.81-93.3%

Contact Information

Aerovate Therapeutics, Inc.
930 Winter Street
Suite M-500
Waltham, MA 02451
United States

Aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate’s initial focus is on advancing AV-101, its dry powder inhaled formulation of the drug imatinib for the treatment of pulmonary arterial hypertension, or PAH.